We believe that the best solution for patients doesn’t lie in a single drug but in a unique combination of medicines. TG Therapeutics was founded with one goal in mind—to leverage scientific advances in
B-cell biology to develop novel treatments for patients.
We’ve dedicated ourselves to this simple concept and to the study of
B-cells and B-cell diseases. To achieve our goal, we search the globe looking for medicines in early research that we believe could be combined to create better treatment options for patients.
The team’s dedication and hard work over the last 9 years has brought us to where we are today. With 5 unique medicines under development and 4 potential approvals in 2021-2022, we have a lot to be proud of—not to mention the small group who formed TG Therapeutics that are still with us today.